India’s much-hyped April missile interceptor test may not have been the great success the military initially claimed, the New Indian Express reports.
Immediately after the April 27 test, an unidentified Indian Defense Research and Development Organization senior scientist was quoted by the Indian Statesman as calling the maiden test of the Prithvi Defense Vehicle “a complete success as it met all of its objectives without any flaws.”
But the Express newspaper reported on Thursday that the interceptor never struck its target. The Prithvi vehicle passed the target, and its warhead failed to detonate, according to sources at the Wheeler Island Integrated Test Range
“The interceptor did not directly hit the target missile,” an anonymous official said. “So it cannot be claimed that a hit-to-kill took place during the mission.”
Additionally, the Prithvi interceptor did not reach its intended height of a minimum of 75 miles.
“The missed distance between the interceptor and the target was more than what was expected,” the official said. “But we still can say that the mission was partially successful as the interceptor could be fired in time. In an automated operation, a radar-based detection and tracking system successfully detected and tracked the enemy ballistic missile.”
DRDO head Avinash Chander is now asserting there never was a plan for the interceptor’s warhead to explode, and that the principal purpose of the test was to monitor the trajectory of the missile target.
Meanwhile, the Indian military is preparing to conduct a test as soon as next month of the nuclear-ready Nirbhay cruise missile, the Times of India reported. This would be the second trial of the weapon, which is said to be capable of being launched from air, sea and land.
The maiden test of the weapon last year ended in failure when the launched missile deviated from its programmed flight course and had to be remotely destroyed. The Nirbhay is reportedly designed to carry nuclear payloads as far as 621 miles and has been compared to the U.S. Tomahawk missile.
What We're Following See More »
Senate Judiciary Committee Chairman Chuck Grassley (R-IA) said Monday he'd now be willing to hold a hearing on Supreme Court nominee Merrick Garland in a lame-duck session of Congress. While he said he wouldn't push for it, he said if "Hillary Clinton wins the White House, and a majority of senators convinced him to do so," he would soften his previous opposition.
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.